{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:49:01Z","timestamp":1794890941845,"version":"4.9.1"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA205067"],"award-info":[{"award-number":["R01CA205067"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2110075"],"award-info":[{"award-number":["W81XWH2110075"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT9425-24-1-0144"],"award-info":[{"award-number":["HT9425-24-1-0144"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Obesity is a known risk factor for many cancers, yet recent studies reveal a paradoxical association between low body mass index (BMI) and increased brain metastasis in lung cancer\u2014referred to as the \u201cobesity paradox,\u201d with unclear molecular mechanism(s). Here, we show a significantly higher incidence of brain metastasis in low-BMI lung cancer patients compared to those with high-BMI or other cancer brain metastasis in a pan-analysis of 7628 patients. Mechanistically, low BMI activates ghrelin-GHSR signaling, increasing neuronal neuropeptide Y (NPY) secretion, which promotes tumor metabolic reprogramming via NPY-Y5R, facilitating brain colonization. Elevated plasma ghrelin levels in cancer-free low-BMI subjects suggest its potential as a prognostic biomarker for predicting brain metastasis. Notably, targeting NPY-Y5R or reversing low BMI effectively suppresses brain metastasis, supporting its pro-metastatic role. These findings provide a strong rationale for developing targeted interventions to treat or prevent brain metastasis in lung cancer patients with low BMI.<\/jats:p>","DOI":"10.1038\/s41467-025-60730-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:39:36Z","timestamp":1751355576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-2099","authenticated-orcid":false,"given":"Abhishek","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4634-9967","authenticated-orcid":false,"given":"Ravindra Pramod","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5504-8875","authenticated-orcid":false,"given":"Kerui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-3650","authenticated-orcid":false,"given":"Giuseppe L.","family":"Banna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7441-6322","authenticated-orcid":false,"given":"Kounosuke","family":"Watabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"60730_CR1","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","volume":"23","author":"N Lamba","year":"2021","unstructured":"Lamba, N., Wen, P. Y. & Aizer, A. A. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 23, 1447\u20131456 (2021).","journal-title":"Neuro Oncol."},{"key":"60730_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nec.2020.06.001","volume":"31","author":"P Sacks","year":"2020","unstructured":"Sacks, P. & Rahman, M. Epidemiology of brain metastases. Neurosurg. Clin. N. Am. 31, 481\u2013488 (2020).","journal-title":"Neurosurg. Clin. N. Am."},{"key":"60730_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","volume":"17","author":"JH Suh","year":"2020","unstructured":"Suh, J. H. et al. Current approaches to the management of brain metastases. Nat. Rev. Clin. Oncol. 17, 279\u2013299 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"60730_CR4","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/jamaoncol.2022.1928","volume":"8","author":"NS Moss","year":"2022","unstructured":"Moss, N. S., Beal, K. & Tabar, V. Brain metastasis-a distinct oncologic disease best served by an integrated multidisciplinary team approach. JAMA Oncol. 8, 1252\u20131254 (2022).","journal-title":"JAMA Oncol."},{"key":"60730_CR5","doi-asserted-by":"publisher","first-page":"6357","DOI":"10.1002\/cam4.1865","volume":"7","author":"N An","year":"2018","unstructured":"An, N. et al. Risk factors for brain metastases in patients with non-small-cell lung cancer. Cancer Med 7, 6357\u20136364 (2018).","journal-title":"Cancer Med"},{"key":"60730_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/neuonc\/nos087","volume":"14","author":"JS Barnholtz-Sloan","year":"2012","unstructured":"Barnholtz-Sloan, J. S. et al. A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro Oncol. 14, 910\u2013918 (2012).","journal-title":"Neuro Oncol."},{"key":"60730_CR7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.7314\/APJCP.2014.15.3.1233","volume":"15","author":"DS Sun","year":"2014","unstructured":"Sun, D. S. et al. A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer. Asian Pac. J. Cancer Prev. 15, 1233\u20131239 (2014).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"60730_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/COC.0000000000000230","volume":"41","author":"SN Waqar","year":"2018","unstructured":"Waqar, S. N. et al. Brain metastases at presentation in patients with non-small cell lung cancer. Am. J. Clin. Oncol. 41, 36\u201340 (2018).","journal-title":"Am. J. Clin. Oncol."},{"key":"60730_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.851629","volume":"9","author":"Y He","year":"2022","unstructured":"He, Y. et al. Association of underweight and weight loss with poor prognosis and poor therapy effectiveness in brain metastases: a retrospective study. Front Nutr. 9, 851629 (2022).","journal-title":"Front Nutr."},{"key":"60730_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11060-019-03300-1","volume":"145","author":"A Lareida","year":"2019","unstructured":"Lareida, A. et al. Underweight and weight loss are predictors of poor outcome in patients with brain metastasis. J. Neurooncol 145, 339\u2013347 (2019).","journal-title":"J. Neurooncol"},{"key":"60730_CR11","doi-asserted-by":"crossref","unstructured":"Masel E. K. et al. Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: a retrospective analysis of 624 patients. Eur. J. Cancer Care (Engl) 26, 1\u20135 (2017).","DOI":"10.1111\/ecc.12707"},{"key":"60730_CR12","doi-asserted-by":"publisher","first-page":"e0218825","DOI":"10.1371\/journal.pone.0218825","volume":"14","author":"MW Nam","year":"2019","unstructured":"Nam, M. W., Kim, J. M., Cheong, J. H., Ryu, J. I. & Han, M. H. Paradoxical relationship between body mass index and bone mineral density in patients with non-small cell lung cancer with brain metastasis. PLoS One 14, e0218825 (2019).","journal-title":"PLoS One"},{"key":"60730_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/cam4.634","volume":"5","author":"NM Tsang","year":"2016","unstructured":"Tsang, N. M. et al. Overweight and obesity predict better overall survival rates in cancer patients with distant metastases. Cancer Med 5, 665\u2013675 (2016).","journal-title":"Cancer Med"},{"key":"60730_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108985","volume":"110","author":"GL Banna","year":"2022","unstructured":"Banna, G. L. et al. Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: the Spinnaker retrospective study. Int Immunopharmacol. 110, 108985 (2022).","journal-title":"Int Immunopharmacol."},{"key":"60730_CR15","doi-asserted-by":"crossref","unstructured":"Cortellini A. et al. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression >\/= 50%: a multicenter study with external validation. J. Immunother. Cancer 8, e001403 (2020).","DOI":"10.1136\/jitc-2020-001403"},{"key":"60730_CR16","doi-asserted-by":"crossref","unstructured":"Cortellini A. et al. Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations. J. Immunother. Cancer 10, e004374 (2022).","DOI":"10.1136\/jitc-2021-004374"},{"key":"60730_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.lungcan.2020.09.007","volume":"149","author":"G Crane","year":"2020","unstructured":"Crane, G. et al. Application of clinical trial inclusion criteria to clinical practice patients to quantify the burden of CNS metastases on health-related quality of life and healthcare resource use in patients with NSCLC. Lung Cancer 149, 144\u2013153 (2020).","journal-title":"Lung Cancer"},{"key":"60730_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/bjc.2016.431","volume":"116","author":"LE Daly","year":"2017","unstructured":"Daly, L. E. et al. The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma. Br. J. Cancer 116, 310\u2013317 (2017).","journal-title":"Br. J. Cancer"},{"key":"60730_CR19","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1002\/cncr.27434","volume":"118","author":"S Dawood","year":"2012","unstructured":"Dawood, S. et al. Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer. Cancer 118, 4652\u20134659 (2012).","journal-title":"Cancer"},{"key":"60730_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.annonc.2020.12.012","volume":"32","author":"Y Di Filippo","year":"2021","unstructured":"Di Filippo, Y. et al. Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data(\u2606). Ann. Oncol. 32, 542\u2013551 (2021).","journal-title":"Ann. Oncol."},{"key":"60730_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10549-023-07108-6","volume":"203","author":"SWM Lammers","year":"2024","unstructured":"Lammers, S. W. M. et al. The prognostic impact of BMI in patients with HR+\/HER2- advanced breast cancer: a study of the SONABRE registry. Breast Cancer Res Treat. 203, 339\u2013349 (2024).","journal-title":"Breast Cancer Res Treat."},{"key":"60730_CR22","doi-asserted-by":"crossref","unstructured":"Santoni M. et al. Body mass index in patients treated with cabozantinib for advanced renal cell carcinoma: a new prognostic factor? Diagnostics (Basel) 11, 138 (2021).","DOI":"10.3390\/diagnostics11010138"},{"key":"60730_CR23","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/j.clgc.2023.03.006","volume":"21","author":"M Santoni","year":"2023","unstructured":"Santoni, M. et al. Clinico-pathological features influencing the prognostic role of body mass index in patients with advanced renal cell carcinoma treated by immuno-oncology combinations (ARON-1). Clin. Genitourin. Cancer 21, e309\u2013e319 e301 (2023).","journal-title":"Clin. Genitourin. Cancer"},{"key":"60730_CR24","doi-asserted-by":"crossref","unstructured":"Siringo M. et al. Evaluation of efficacy of ALK Inhibitors according to body mass index in ALK rearranged NSCLC patients-a retrospective observational study. Cancers (Basel) 15, 3422 (2023).","DOI":"10.3390\/cancers15133422"},{"key":"60730_CR25","doi-asserted-by":"crossref","unstructured":"Chen Y. M. et al. Body mass index, weight loss, and mortality risk in advanced-stage non-small cell lung cancer patients: a focus on EGFR mutation. Nutrients 13, 3761 (2021).","DOI":"10.3390\/nu13113761"},{"key":"60730_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.lungcan.2013.08.004","volume":"82","author":"SH Hsiao","year":"2013","unstructured":"Hsiao, S. H. et al. Identification of subgroup patients with stage IIIB\/IV non-small cell lung cancer at higher risk for brain metastases. Lung Cancer 82, 319\u2013323 (2013).","journal-title":"Lung Cancer"},{"key":"60730_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12931-021-01741-9","volume":"22","author":"C Li","year":"2021","unstructured":"Li, C. et al. Osimertinib alone as second-line treatment for brain metastases (BM) control may be more limited than for non-BM in advanced NSCLC patients with an acquired EGFR T790M mutation. Respir. Res 22, 145 (2021).","journal-title":"Respir. Res"},{"key":"60730_CR28","doi-asserted-by":"publisher","first-page":"e1075","DOI":"10.1093\/oncolo\/oyad170","volume":"28","author":"EN Smyth","year":"2023","unstructured":"Smyth, E. N. et al. Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United States. Oncologist 28, e1075\u2013e1091 (2023).","journal-title":"Oncologist"},{"key":"60730_CR29","doi-asserted-by":"publisher","first-page":"790","DOI":"10.21037\/tlcr-20-1020","volume":"10","author":"R Teocharoen","year":"2021","unstructured":"Teocharoen, R., Ruangritchankul, K., Vinayanuwattikun, C., Sriuranpong, V. & Sitthideatphaiboon, P. Vimentin expression status is a potential biomarker for brain metastasis development in EGFR-mutant NSCLC patients. Transl. Lung Cancer Res 10, 790\u2013801 (2021).","journal-title":"Transl. Lung Cancer Res"},{"key":"60730_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579\u2013591 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"60730_CR31","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ncb3578","volume":"19","author":"DF Quail","year":"2017","unstructured":"Quail, D. F. et al. Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. Nat. Cell Biol. 19, 974\u2013987 (2017).","journal-title":"Nat. Cell Biol."},{"key":"60730_CR32","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1172\/JCI29867","volume":"116","author":"A Abizaid","year":"2006","unstructured":"Abizaid, A. et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest 116, 3229\u20133239 (2006).","journal-title":"J. Clin. Invest"},{"key":"60730_CR33","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1124\/jpet.102.034827","volume":"302","author":"WA Banks","year":"2002","unstructured":"Banks, W. A., Tschop, M., Robinson, S. M. & Heiman, M. L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J. Pharm. Exp. Ther. 302, 822\u2013827 (2002).","journal-title":"J. Pharm. Exp. Ther."},{"key":"60730_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0896-6273(03)00063-1","volume":"37","author":"MA Cowley","year":"2003","unstructured":"Cowley, M. A. et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649\u2013661 (2003).","journal-title":"Neuron"},{"key":"60730_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/archsurg.138.4.389","volume":"138","author":"DE Cummings","year":"2003","unstructured":"Cummings, D. E. & Shannon, M. H. Roles for ghrelin in the regulation of appetite and body weight. Arch. Surg. 138, 389\u2013396 (2003).","journal-title":"Arch. Surg."},{"key":"60730_CR36","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.273.5277.974","volume":"273","author":"AD Howard","year":"1996","unstructured":"Howard, A. D. et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273, 974\u2013977 (1996).","journal-title":"Science"},{"key":"60730_CR37","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656\u2013660 (1999).","journal-title":"Nature"},{"key":"60730_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/35051587","volume":"409","author":"M Nakazato","year":"2001","unstructured":"Nakazato, M. et al. A role for ghrelin in the central regulation of feeding. Nature 409, 194\u2013198 (2001).","journal-title":"Nature"},{"key":"60730_CR39","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1007\/s12035-018-1362-8","volume":"56","author":"M Uriarte","year":"2019","unstructured":"Uriarte, M. et al. Evidence Supporting a Role for the Blood-Cerebrospinal Fluid Barrier Transporting Circulating Ghrelin into the Brain. Mol. Neurobiol. 56, 4120\u20134134 (2019).","journal-title":"Mol. Neurobiol."},{"key":"60730_CR40","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","volume":"50","author":"DE Cummings","year":"2001","unstructured":"Cummings, D. E. et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714\u20131719 (2001).","journal-title":"Diabetes"},{"key":"60730_CR41","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1210\/jc.2003-032007","volume":"89","author":"MJ De Souza","year":"2004","unstructured":"De Souza, M. J., Leidy, H. J., O\u2019Donnell, E., Lasley, B. & Williams, N. I. Fasting ghrelin levels in physically active women: relationship with menstrual disturbances and metabolic hormones. J. Clin. Endocrinol. Metab. 89, 3536\u20133542 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60730_CR42","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1210\/jc.2003-031328","volume":"89","author":"P Marzullo","year":"2004","unstructured":"Marzullo, P. et al. The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J. Clin. Endocrinol. Metab. 89, 936\u2013939 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60730_CR43","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/jcem.87.1.8129","volume":"87","author":"T Shiiya","year":"2002","unstructured":"Shiiya, T. et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 87, 240\u2013244 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60730_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11695-008-9748-8","volume":"19","author":"J Ybarra","year":"2009","unstructured":"Ybarra, J. et al. Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss. Obes. Surg. 19, 327\u2013331 (2009).","journal-title":"Obes. Surg."},{"key":"60730_CR45","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1530\/eje.0.1510573","volume":"151","author":"A Katsuki","year":"2004","unstructured":"Katsuki, A. et al. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. Eur. J. Endocrinol. 151, 573\u2013577 (2004).","journal-title":"Eur. J. Endocrinol."},{"key":"60730_CR46","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/oby.2005.83","volume":"13","author":"ME Valera Mora","year":"2005","unstructured":"Valera Mora, M. E. et al. Ghrelin does not influence gastric emptying in obese subjects. Obes. Res 13, 739\u2013744 (2005).","journal-title":"Obes. Res"},{"key":"60730_CR47","unstructured":"Sjostedt E. et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science 367, eaay5947 (2020)."},{"key":"60730_CR48","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1111\/ejn.13013","volume":"42","author":"M Cavalier","year":"2015","unstructured":"Cavalier, M. et al. Involvement of PKA and ERK pathways in ghrelin-induced long-lasting potentiation of excitatory synaptic transmission in the CA1 area of rat hippocampus. Eur. J. Neurosci. 42, 2568\u20132576 (2015).","journal-title":"Eur. J. Neurosci."},{"key":"60730_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nn1810","volume":"10","author":"D Sieburth","year":"2007","unstructured":"Sieburth, D., Madison, J. M. & Kaplan, J. M. PKC-1 regulates secretion of neuropeptides. Nat. Neurosci. 10, 49\u201357 (2007).","journal-title":"Nat. Neurosci."},{"key":"60730_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33365-y","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis. Nat. Commun. 13, 5983 (2022).","journal-title":"Nat. Commun."},{"key":"60730_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50099-y","volume":"9","author":"T Iwamoto","year":"2019","unstructured":"Iwamoto, T. et al. Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples. Sci. Rep. 9, 13343 (2019).","journal-title":"Sci. Rep."},{"key":"60730_CR52","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/hmg\/ddt420","volume":"23","author":"DM Marzese","year":"2014","unstructured":"Marzese, D. M. et al. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum. Mol. Genet 23, 226\u2013238 (2014).","journal-title":"Hum. Mol. Genet"},{"key":"60730_CR53","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1158\/1078-0432.CCR-13-3003","volume":"20","author":"G Chen","year":"2014","unstructured":"Chen, G. et al. Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target. Clin. Cancer Res 20, 5537\u20135546 (2014).","journal-title":"Clin. Cancer Res"},{"key":"60730_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-393","volume":"15","author":"MG Hollingshead","year":"2014","unstructured":"Hollingshead, M. G. et al. Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages\u2013strategies for data mining in support of therapeutic studies. BMC Genomics 15, 393 (2014).","journal-title":"BMC Genomics"},{"key":"60730_CR55","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41591-019-0750-6","volume":"26","author":"AM Laughney","year":"2020","unstructured":"Laughney, A. M. et al. Regenerative lineages and immune-mediated pruning in lung cancer metastasis. Nat. Med 26, 259\u2013269 (2020).","journal-title":"Nat. Med"},{"key":"60730_CR56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ccr.2009.05.017","volume":"16","author":"XH Zhang","year":"2009","unstructured":"Zhang, X. H. et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 16, 67\u201378 (2009).","journal-title":"Cancer Cell"},{"key":"60730_CR57","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1172\/JCI131919","volume":"130","author":"P Dietrich","year":"2020","unstructured":"Dietrich, P. et al. Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer. J. Clin. Invest 130, 2509\u20132526 (2020).","journal-title":"J. Clin. Invest"},{"key":"60730_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29898-x","volume":"13","author":"C Lu","year":"2022","unstructured":"Lu, C. et al. Hypoxia-activated neuropeptide Y\/Y5 receptor\/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma. Nat. Commun. 13, 2323 (2022).","journal-title":"Nat. Commun."},{"key":"60730_CR59","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1523\/JNEUROSCI.18-15-05565.1998","volume":"18","author":"Y Dumont","year":"1998","unstructured":"Dumont, Y., Fournier, A. & Quirion, R. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J. Neurosci. 18, 5565\u20135574 (1998).","journal-title":"J. Neurosci."},{"key":"60730_CR60","doi-asserted-by":"publisher","first-page":"10295","DOI":"10.1523\/JNEUROSCI.19-23-10295.1999","volume":"19","author":"KA Nichol","year":"1999","unstructured":"Nichol, K. A. et al. Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control. J. Neurosci. 19, 10295\u201310304 (1999).","journal-title":"J. Neurosci."},{"key":"60730_CR61","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60730_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200111","volume":"6","author":"Y Wu","year":"2022","unstructured":"Wu, Y., Berisha, A. & Borniger, J. C. Neuropeptides in Cancer: Friend and Foe?. Adv. Biol. (Weinh.) 6, e2200111 (2022).","journal-title":"Adv. Biol. (Weinh.)"},{"key":"60730_CR63","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000486225","volume":"45","author":"M Yi","year":"2018","unstructured":"Yi, M. et al. A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans. Cell Physiol. Biochem 45, 88\u2013107 (2018).","journal-title":"Cell Physiol. Biochem"},{"key":"60730_CR64","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1158\/0008-5472.CAN-16-0266","volume":"76","author":"C Lehuede","year":"2016","unstructured":"Lehuede, C., Dupuy, F., Rabinovitch, R., Jones, R. G. & Siegel, P. M. Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis. Cancer Res 76, 5201\u20135208 (2016).","journal-title":"Cancer Res"},{"key":"60730_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215713","volume":"539","author":"A Tyagi","year":"2022","unstructured":"Tyagi, A., Wu, S. Y. & Watabe, K. Metabolism in the progression and metastasis of brain tumors. Cancer Lett. 539, 215713 (2022).","journal-title":"Cancer Lett."},{"key":"60730_CR66","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano, H. & Sato, R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat. Rev. Endocrinol. 13, 710\u2013730 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"60730_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100741","volume":"8","author":"N Woldmar","year":"2023","unstructured":"Woldmar, N. et al. Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases. ESMO Open 8, 100741 (2023).","journal-title":"ESMO Open"},{"key":"60730_CR68","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s42255-022-00568-y","volume":"4","author":"C Cheng","year":"2022","unstructured":"Cheng, C. et al. Ammonia stimulates SCAP\/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth. Nat. Metab. 4, 575\u2013588 (2022).","journal-title":"Nat. Metab."},{"key":"60730_CR69","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cmet.2006.08.002","volume":"4","author":"N Erondu","year":"2006","unstructured":"Erondu, N. et al. Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults. Cell Metab. 4, 275\u2013282 (2006).","journal-title":"Cell Metab."},{"key":"60730_CR70","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/oby.2007.620","volume":"15","author":"N Erondu","year":"2007","unstructured":"Erondu, N. et al. Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss. Obes. (Silver Spring) 15, 895\u2013905 (2007).","journal-title":"Obes. (Silver Spring)"},{"key":"60730_CR71","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","volume":"16","author":"M Arnold","year":"2015","unstructured":"Arnold, M. et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 16, 36\u201346 (2015).","journal-title":"Lancet Oncol."},{"key":"60730_CR72","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","volume":"384","author":"K Bhaskaran","year":"2014","unstructured":"Bhaskaran, K. et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384, 755\u2013765 (2014).","journal-title":"Lancet"},{"key":"60730_CR73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2012.113905","volume":"309","author":"KM Flegal","year":"2013","unstructured":"Flegal, K. M., Kit, B. K., Orpana, H. & Graubard, B. I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309, 71\u201382 (2013).","journal-title":"JAMA"},{"key":"60730_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01877-3","volume":"19","author":"M Recalde","year":"2021","unstructured":"Recalde, M. et al. Body mass index and waist circumference in relation to the risk of 26 types of cancer: a prospective cohort study of 3.5 million adults in Spain. BMC Med 19, 10 (2021).","journal-title":"BMC Med"},{"key":"60730_CR75","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.lungcan.2016.10.017","volume":"102","author":"A Gupta","year":"2016","unstructured":"Gupta, A. et al. Premorbid body mass index and mortality in patients with lung cancer: A systematic review and meta-analysis. Lung Cancer 102, 49\u201359 (2016).","journal-title":"Lung Cancer"},{"key":"60730_CR76","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.lungcan.2020.11.029","volume":"152","author":"M Jiang","year":"2021","unstructured":"Jiang, M. et al. The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients. Lung Cancer 152, 58\u201365 (2021).","journal-title":"Lung Cancer"},{"key":"60730_CR77","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/jnci\/djs179","volume":"104","author":"L Smith","year":"2012","unstructured":"Smith, L. et al. Body mass index and risk of lung cancer among never, former, and current smokers. J. Natl Cancer Inst. 104, 778\u2013789 (2012).","journal-title":"J. Natl Cancer Inst."},{"key":"60730_CR78","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/JTO.0b013e31829cf942","volume":"8","author":"SE Dahlberg","year":"2013","unstructured":"Dahlberg, S. E. et al. Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials. J. Thorac. Oncol. 8, 1121\u20131127 (2013).","journal-title":"J. Thorac. Oncol."},{"key":"60730_CR79","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lungcan.2016.11.017","volume":"104","author":"VK Lam","year":"2017","unstructured":"Lam, V. K. et al. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC). Lung Cancer 104, 52\u201357 (2017).","journal-title":"Lung Cancer"},{"key":"60730_CR80","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-016-0539-4","volume":"18","author":"H Lennon","year":"2016","unstructured":"Lennon, H., Sperrin, M., Badrick, E. & Renehan, A. G. The Obesity Paradox in Cancer: a Review. Curr. Oncol. Rep. 18, 56 (2016).","journal-title":"Curr. Oncol. Rep."},{"key":"60730_CR81","doi-asserted-by":"crossref","unstructured":"Nitsche L. J. et al. Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies. Cancers (Basel) 14, (2022).","DOI":"10.3390\/cancers14061440"},{"key":"60730_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-021-00834-2","volume":"11","author":"J Han","year":"2021","unstructured":"Han, J. et al. Imaging modalities for diagnosis and monitoring of cancer cachexia. EJNMMI Res 11, 94 (2021).","journal-title":"EJNMMI Res"},{"key":"60730_CR83","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/ajcn\/nqac031","volume":"115","author":"KD Hall","year":"2022","unstructured":"Hall, K. D. et al. The energy balance model of obesity: beyond calories in, calories out. Am. J. Clin. Nutr. 115, 1243\u20131254 (2022).","journal-title":"Am. J. Clin. Nutr."},{"key":"60730_CR84","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000504874","volume":"75","author":"G Ulmann","year":"2019","unstructured":"Ulmann, G. et al. Lean Body Mass and Endocrine Status But Not Age Are Determinants of Resting Energy Expenditure in Patients with Non-Small Cell Lung Cancer. Ann. Nutr. Metab. 75, 223\u2013230 (2019).","journal-title":"Ann. Nutr. Metab."},{"key":"60730_CR85","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.cmet.2022.05.012","volume":"34","author":"S Hu","year":"2022","unstructured":"Hu, S. et al. Higher than predicted resting energy expenditure and lower physical activity in healthy underweight Chinese adults. Cell Metab. 34, 1413\u20131415 (2022).","journal-title":"Cell Metab."},{"key":"60730_CR86","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.clnu.2019.08.003","volume":"39","author":"A Jouinot","year":"2020","unstructured":"Jouinot, A. et al. Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients. Clin. Nutr. 39, 1893\u20131899 (2020).","journal-title":"Clin. Nutr."},{"key":"60730_CR87","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1210\/endo.141.11.7873","volume":"141","author":"AM Wren","year":"2000","unstructured":"Wren, A. M. et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325\u20134328 (2000).","journal-title":"Endocrinology"},{"key":"60730_CR88","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1073\/pnas.1212137110","volume":"110","author":"M Schaeffer","year":"2013","unstructured":"Schaeffer, M. et al. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proc. Natl Acad. Sci. USA 110, 1512\u20131517 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60730_CR89","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1507\/endocrj.EJ14-0436","volume":"62","author":"Y Kim","year":"2015","unstructured":"Kim, Y. et al. Ghrelin is required for dietary restriction-induced enhancement of hippocampal neurogenesis: lessons from ghrelin knockout mice. Endocr. J. 62, 269\u2013275 (2015).","journal-title":"Endocr. J."},{"key":"60730_CR90","doi-asserted-by":"crossref","unstructured":"Sassi, M., Morgan, A. H. & Davies, J. S. Ghrelin acylation-a post-translational tuning mechanism regulating adult hippocampal neurogenesis. Cells 11, 765 (2022).","DOI":"10.3390\/cells11050765"},{"key":"60730_CR91","doi-asserted-by":"crossref","unstructured":"Frago, L. M., Chowen, J. A. Involvement of astrocytes in mediating the central effects of ghrelin. Int. J. Mol. Sci. 18, 536 (2017).","DOI":"10.3390\/ijms18030536"},{"key":"60730_CR92","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3803\/EnM.2014.29.3.371","volume":"29","author":"JY Lee","year":"2014","unstructured":"Lee, J. Y. & Yune, T. Y. Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation. Endocrinol. Metab. (Seoul.) 29, 371\u2013378 (2014).","journal-title":"Endocrinol. Metab. (Seoul.)"},{"key":"60730_CR93","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12640-009-9037-x","volume":"15","author":"M Moon","year":"2009","unstructured":"Moon, M. et al. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease by blocking microglial activation. Neurotox. Res 15, 332\u2013347 (2009).","journal-title":"Neurotox. Res"},{"key":"60730_CR94","doi-asserted-by":"crossref","unstructured":"Tian R. & Mao G. Ghrelin reduces cerebral ischemic injury in rats by reducing M1 microglia\/macrophages. Eur. J. Histochem. 66, 3350 (2022).","DOI":"10.4081\/ejh.2022.3350"},{"key":"60730_CR95","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nn1656","volume":"9","author":"S Diano","year":"2006","unstructured":"Diano, S. et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 9, 381\u2013388 (2006).","journal-title":"Nat. Neurosci."},{"key":"60730_CR96","doi-asserted-by":"crossref","unstructured":"Chuang, J. C., Zigman, J. M. Ghrelin\u2019s roles in stress, mood, and anxiety regulation. Int. J. Pept. 2010, 460549 (2010).","DOI":"10.1155\/2010\/460549"},{"key":"60730_CR97","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/nn.2139","volume":"11","author":"M Lutter","year":"2008","unstructured":"Lutter, M. et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat. Neurosci. 11, 752\u2013753 (2008).","journal-title":"Nat. Neurosci."},{"key":"60730_CR98","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1172\/JCI30248","volume":"117","author":"VD Dixit","year":"2007","unstructured":"Dixit, V. D. et al. Ghrelin promotes thymopoiesis during aging. J. Clin. Invest 117, 2778\u20132790 (2007).","journal-title":"J. Clin. Invest"},{"key":"60730_CR99","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fphys.2017.00119","volume":"8","author":"S Blauwhoff-Buskermolen","year":"2017","unstructured":"Blauwhoff-Buskermolen, S. et al. Plasma ghrelin levels are associated with anorexia but not cachexia in patients with NSCLC. Front Physiol. 8, 119 (2017).","journal-title":"Front Physiol."},{"key":"60730_CR100","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.lungcan.2009.02.006","volume":"66","author":"EM Karapanagiotou","year":"2009","unstructured":"Karapanagiotou, E. M. et al. Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients. Lung Cancer 66, 393\u2013398 (2009).","journal-title":"Lung Cancer"},{"key":"60730_CR101","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/oby.2007.542","volume":"15","author":"HJ Leidy","year":"2007","unstructured":"Leidy, H. J., Dougherty, K. A., Frye, B. R., Duke, K. M. & Williams, N. I. Twenty-four-hour ghrelin is elevated after calorie restriction and exercise training in non-obese women. Obes. (Silver Spring) 15, 446\u2013455 (2007).","journal-title":"Obes. (Silver Spring)"},{"key":"60730_CR102","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3889\/oamjms.2017.182","volume":"5","author":"D Papandreou","year":"2017","unstructured":"Papandreou, D., Karavolias, C., Arvaniti, F., Kafeza, E. & Sidawi, F. Fasting ghrelin levels are decreased in obese subjects and are significantly related with insulin resistance and body mass index. Open Access Maced. J. Med Sci. 5, 699\u2013702 (2017).","journal-title":"Open Access Maced. J. Med Sci."},{"key":"60730_CR103","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","volume":"50","author":"M Tschop","year":"2001","unstructured":"Tschop, M. et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 50, 707\u2013709 (2001).","journal-title":"Diabetes"},{"key":"60730_CR104","doi-asserted-by":"crossref","unstructured":"Au C. C. et al. Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531. Elife 9, e56913(2020).","DOI":"10.7554\/eLife.56913"},{"key":"60730_CR105","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/cas.12725","volume":"106","author":"M Kawaguchi","year":"2015","unstructured":"Kawaguchi, M. et al. Ghrelin administration suppresses inflammation-associated colorectal carcinogenesis in mice. Cancer Sci. 106, 1130\u20131136 (2015).","journal-title":"Cancer Sci."},{"key":"60730_CR106","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1734-1140(12)70890-3","volume":"64","author":"H Lawnicka","year":"2012","unstructured":"Lawnicka, H., Melen-Mucha, G., Motylewska, E., Mucha, S. & Stepien, H. Modulation of ghrelin axis influences the growth of colonic and prostatic cancer cells in vitro. Pharm. Rep. 64, 951\u2013959 (2012).","journal-title":"Pharm. Rep."},{"key":"60730_CR107","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1007\/s00429-018-1682-5","volume":"223","author":"MP Cornejo","year":"2018","unstructured":"Cornejo, M. P. et al. Ghrelin receptor signaling targets segregated clusters of neurons within the nucleus of the solitary tract. Brain Struct. Funct. 223, 3133\u20133147 (2018).","journal-title":"Brain Struct. Funct."},{"key":"60730_CR108","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1101\/sqb.2011.76.010447","volume":"76","author":"JL Goldstein","year":"2011","unstructured":"Goldstein, J. L. et al. Surviving starvation: essential role of the ghrelin-growth hormone axis. Cold Spring Harb. Symp. Quant. Biol. 76, 121\u2013127 (2011).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"60730_CR109","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.psyneuen.2015.09.023","volume":"63","author":"AK Hornsby","year":"2016","unstructured":"Hornsby, A. K. et al. Short-term calorie restriction enhances adult hippocampal neurogenesis and remote fear memory in a Ghsr-dependent manner. Psychoneuroendocrinology 63, 198\u2013207 (2016).","journal-title":"Psychoneuroendocrinology"},{"key":"60730_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12763","volume":"31","author":"CS Wu","year":"2019","unstructured":"Wu, C. S. et al. Ghrelin receptor in agouti-related peptide neurones regulates metabolic adaptation to calorie restriction. J. Neuroendocrinol. 31, e12763 (2019).","journal-title":"J. Neuroendocrinol."},{"key":"60730_CR111","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/jdi.12580","volume":"8","author":"S Chen","year":"2017","unstructured":"Chen, S. et al. Ghrelin is a possible new predictor associated with executive function in patients with type 2 diabetes mellitus. J. Diabetes Investig. 8, 306\u2013313 (2017).","journal-title":"J. Diabetes Investig."},{"key":"60730_CR112","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1365-2125.2009.03372.x","volume":"68","author":"MP Doogue","year":"2009","unstructured":"Doogue, M. P. et al. Metformin increases plasma ghrelin in Type 2 diabetes. Br. J. Clin. Pharm. 68, 875\u2013882 (2009).","journal-title":"Br. J. Clin. Pharm."},{"key":"60730_CR113","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/dmrr.681","volume":"23","author":"PJ English","year":"2007","unstructured":"English, P. J. et al. Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes. Diabetes Metab. Res Rev. 23, 299\u2013303 (2007).","journal-title":"Diabetes Metab. Res Rev."},{"key":"60730_CR114","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/1753-0407.12445","volume":"9","author":"S Ida","year":"2017","unstructured":"Ida, S., Murata, K. & Kaneko, R. Effects of metformin treatment on blood leptin and ghrelin levels in patients with type 2 diabetes mellitus. J. Diabetes 9, 526\u2013535 (2017).","journal-title":"J. Diabetes"},{"key":"60730_CR115","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.2337\/diabetes.52.10.2546","volume":"52","author":"SM Poykko","year":"2003","unstructured":"Poykko, S. M. et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52, 2546\u20132553 (2003).","journal-title":"Diabetes"},{"key":"60730_CR116","doi-asserted-by":"publisher","first-page":"1075823","DOI":"10.3389\/fonc.2023.1075823","volume":"13","author":"RC Augustin","year":"2023","unstructured":"Augustin, R. C. et al. Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study. Front Oncol. 13, 1075823 (2023).","journal-title":"Front Oncol."},{"key":"60730_CR117","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/j.ijrobp.2018.07.1012","volume":"102","author":"MC LeCompte","year":"2018","unstructured":"LeCompte, M. C. et al. Impact of Diabetes Mellitus and Metformin on Clinical Outcomes of Brain Metastasis Patients Treated with Stereotactic Radiosurgery. Int. J. Radiat. Oncol., Biol., Phys. 102, e328 (2018).","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"key":"60730_CR118","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jtho.2020.08.021","volume":"16","author":"J Kang","year":"2021","unstructured":"Kang, J. et al. The associations of aspirin, statins, and metformin with lung cancer risk and related mortality: a time-dependent analysis of population-based nationally representative data. J. Thorac. Oncol. 16, 76\u201388 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"60730_CR119","doi-asserted-by":"publisher","first-page":"41132","DOI":"10.18632\/oncotarget.17066","volume":"8","author":"CH Tseng","year":"2017","unstructured":"Tseng, C. H. Metformin and lung cancer risk in patients with type 2 diabetes mellitus. Oncotarget 8, 41132\u201341142 (2017).","journal-title":"Oncotarget"},{"key":"60730_CR120","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/jcpt.13167","volume":"45","author":"K Xiao","year":"2020","unstructured":"Xiao, K. et al. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis. J. Clin. Pharm. Ther. 45, 783\u2013792 (2020).","journal-title":"J. Clin. Pharm. Ther."},{"key":"60730_CR121","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6230162","volume":"2019","author":"L Yao","year":"2019","unstructured":"Yao, L. et al. Metformin use and lung cancer risk in diabetic patients: a systematic review and meta-analysis. Dis. Markers 2019, 6230162 (2019).","journal-title":"Dis. Markers"},{"key":"60730_CR122","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/1082","volume":"1","author":"TM Hahn","year":"1998","unstructured":"Hahn, T. M., Breininger, J. F., Baskin, D. G. & Schwartz, M. W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1, 271\u2013272 (1998).","journal-title":"Nat. Neurosci."},{"key":"60730_CR123","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.psyneuen.2007.03.002","volume":"32","author":"R Nergardh","year":"2007","unstructured":"Nergardh, R. et al. Neuropeptide Y facilitates activity-based-anorexia. Psychoneuroendocrinology 32, 493\u2013502 (2007).","journal-title":"Psychoneuroendocrinology"},{"key":"60730_CR124","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2016.02.037","volume":"618","author":"GN Ruegsegger","year":"2016","unstructured":"Ruegsegger, G. N. et al. Hypothalamic Npy mRNA is correlated with increased wheel running and decreased body fat in calorie-restricted rats. Neurosci. Lett. 618, 83\u201388 (2016).","journal-title":"Neurosci. Lett."},{"key":"60730_CR125","first-page":"E589","volume":"270","author":"T Yoshihara","year":"1996","unstructured":"Yoshihara, T., Honma, S. & Honma, K. Effects of restricted daily feeding on neuropeptide Y release in the rat paraventricular nucleus. Am. J. Physiol. 270, E589\u2013E595 (1996).","journal-title":"Am. J. Physiol."},{"key":"60730_CR126","doi-asserted-by":"publisher","first-page":"7872","DOI":"10.18632\/aging.202805","volume":"13","author":"M Ferreira-Marques","year":"2021","unstructured":"Ferreira-Marques, M., Carvalho, A., Cavadas, C. & Aveleira, C. A. PI3K\/AKT\/MTOR and ERK1\/2-MAPK signaling pathways are involved in autophagy stimulation induced by caloric restriction or caloric restriction mimetics in cortical neurons. Aging (Albany NY) 13, 7872\u20137882 (2021).","journal-title":"Aging (Albany NY)"},{"key":"60730_CR127","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0006-8993(94)90103-1","volume":"646","author":"MG Dube","year":"1994","unstructured":"Dube, M. G., Xu, B., Crowley, W. R., Kalra, P. S. & Kalra, S. P. Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res 646, 341\u2013344 (1994).","journal-title":"Brain Res"},{"key":"60730_CR128","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tem.2015.01.003","volume":"26","author":"K Loh","year":"2015","unstructured":"Loh, K., Herzog, H. & Shi, Y. C. Regulation of energy homeostasis by the NPY system. Trends Endocrinol. Metab. 26, 125\u2013135 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"60730_CR129","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1038\/onc.2014.253","volume":"34","author":"M Czarnecka","year":"2015","unstructured":"Czarnecka, M. et al. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance. Oncogene 34, 3131\u20133143 (2015).","journal-title":"Oncogene"},{"key":"60730_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.peptides.2014.08.004","volume":"61","author":"MC Dvorakova","year":"2014","unstructured":"Dvorakova, M. C., Kruzliak, P. & Rabkin, S. W. Role of neuropeptides in cardiomyopathies. Peptides 61, 1\u20136 (2014).","journal-title":"Peptides"},{"key":"60730_CR131","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ymthe.2023.12.013","volume":"32","author":"YY Qin","year":"2024","unstructured":"Qin, Y. Y. et al. Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction. Mol. Ther. 32, 559\u2013561 (2024).","journal-title":"Mol. Ther."},{"key":"60730_CR132","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10585-017-9864-8","volume":"34","author":"AK Ciminera","year":"2017","unstructured":"Ciminera, A. K., Jandial, R. & Termini, J. Metabolic advantages and vulnerabilities in brain metastases. Clin. Exp. Metastasis 34, 401\u2013410 (2017).","journal-title":"Clin. Exp. Metastasis"},{"key":"60730_CR133","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2018.02.001","volume":"33","author":"T Schild","year":"2018","unstructured":"Schild, T., Low, V., Blenis, J. & Gomes, A. P. Unique metabolic adaptations dictate distal organ-specific metastatic colonization. Cancer Cell 33, 347\u2013354 (2018).","journal-title":"Cancer Cell"},{"key":"60730_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.695623","volume":"9","author":"Y Huang","year":"2021","unstructured":"Huang, Y., Lin, X. & Lin, S. Neuropeptide Y and metabolism syndrome: an update on perspectives of clinical therapeutic intervention strategies. Front Cell Dev. Biol. 9, 695623 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"60730_CR135","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1080\/14728222.2023.2255377","volume":"27","author":"YJ Cheng","year":"2023","unstructured":"Cheng, Y. J., Fan, F., Zhang, Z. & Zhang, H. J. Lipid metabolism in malignant tumor brain metastasis: reprogramming and therapeutic potential. Expert Opin. Ther. Targets 27, 861\u2013878 (2023).","journal-title":"Expert Opin. Ther. Targets"},{"key":"60730_CR136","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie, E., Schulze, A., Zechner, R., Walther, T. C. & Farese, R. V. Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 18, 153\u2013161 (2013).","journal-title":"Cell Metab."},{"key":"60730_CR137","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cmet.2019.04.004","volume":"30","author":"C Duman","year":"2019","unstructured":"Duman, C. et al. Acyl-CoA-binding protein drives glioblastoma tumorigenesis by sustaining fatty acid oxidation. Cell Metab. 30, 274\u2013289 e275 (2019).","journal-title":"Cell Metab."},{"key":"60730_CR138","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s43018-021-00183-y","volume":"2","author":"GB Ferraro","year":"2021","unstructured":"Ferraro, G. B. et al. Fatty acid synthesis is required for breast cancer brain metastasis. Nat. Cancer 2, 414\u2013428 (2021).","journal-title":"Nat. Cancer"},{"key":"60730_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.633210","volume":"11","author":"KJ McKelvey","year":"2021","unstructured":"McKelvey, K. J. et al. Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma. Front Oncol. 11, 633210 (2021).","journal-title":"Front Oncol."},{"key":"60730_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101453","volume":"23","author":"J Sperry","year":"2020","unstructured":"Sperry, J. et al. Glioblastoma utilizes fatty acids and ketone bodies for growth allowing progression during ketogenic diet therapy. iScience 23, 101453 (2020).","journal-title":"iScience"},{"key":"60730_CR141","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1158\/2159-8290.CD-19-0270","volume":"9","author":"Y Zou","year":"2019","unstructured":"Zou, Y. et al. Polyunsaturated fatty acids from astrocytes activate PPARgamma signaling in cancer cells to promote brain metastasis. Cancer Discov. 9, 1720\u20131735 (2019).","journal-title":"Cancer Discov."},{"key":"60730_CR142","doi-asserted-by":"publisher","first-page":"765","DOI":"10.7150\/ijms.92993","volume":"21","author":"Q Deng","year":"2024","unstructured":"Deng, Q. et al. Proteomics-based model for predicting the risk of brain metastasis in patients with resected lung adenocarcinoma carrying the EGFR mutation. Int J. Med Sci. 21, 765\u2013774 (2024).","journal-title":"Int J. Med Sci."},{"key":"60730_CR143","doi-asserted-by":"publisher","first-page":"E108","DOI":"10.1152\/ajpendo.00524.2009","volume":"298","author":"MD Bruss","year":"2010","unstructured":"Bruss, M. D., Khambatta, C. F., Ruby, M. A., Aggarwal, I. & Hellerstein, M. K. Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates. Am. J. Physiol. Endocrinol. Metab. 298, E108\u2013E116 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"60730_CR144","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.stem.2018.04.001","volume":"22","author":"MM Mihaylova","year":"2018","unstructured":"Mihaylova, M. M. et al. Fasting activates fatty acid oxidation to enhance intestinal stem cell function during homeostasis and aging. Cell Stem Cell 22, 769\u2013778.e764 (2018).","journal-title":"Cell Stem Cell"},{"key":"60730_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118478","volume":"262","author":"F Chen","year":"2020","unstructured":"Chen, F., Zhou, Y., Yang, K., Shen, M. & Wang, Y. NPY stimulates cholesterol synthesis acutely by activating the SREBP2-HMGCR pathway through the Y1 and Y5 receptors in murine hepatocytes. Life Sci. 262, 118478 (2020).","journal-title":"Life Sci."},{"key":"60730_CR146","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.npep.2018.05.006","volume":"70","author":"Y Fukasaka","year":"2018","unstructured":"Fukasaka, Y. et al. An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese mice. Neuropeptides 70, 55\u201363 (2018).","journal-title":"Neuropeptides"},{"key":"60730_CR147","doi-asserted-by":"publisher","first-page":"7154","DOI":"10.1073\/pnas.0510320103","volume":"103","author":"A Ishihara","year":"2006","unstructured":"Ishihara, A. et al. A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice. Proc. Natl Acad. Sci. USA 103, 7154\u20137158 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60730_CR148","doi-asserted-by":"crossref","unstructured":"Phelps R. M. et al. NCI-navy medical oncology branch cell line data base. J. Cell Biochem. 24, 32\u201391 (1996).","DOI":"10.1002\/jcb.240630505"},{"key":"60730_CR149","doi-asserted-by":"crossref","unstructured":"Wu S. Y. et al. Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function. J. Exp. Med. 217, e20191131 (2020).","DOI":"10.1084\/jem.20191131"},{"key":"60730_CR150","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1158\/0008-5472.CAN-18-1102","volume":"78","author":"F Xing","year":"2018","unstructured":"Xing, F. et al. Loss of XIST in breast cancer activates MSN-c-met and reprograms microglia via exosomal miRNA to promote brain metastasis. Cancer Res 78, 4316\u20134330 (2018).","journal-title":"Cancer Res"},{"key":"60730_CR151","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.celrep.2019.03.085","volume":"27","author":"E Wingrove","year":"2019","unstructured":"Wingrove, E. et al. Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis. Cell Rep. 27, 1277\u20131292.e1277 (2019).","journal-title":"Cell Rep."},{"key":"60730_CR152","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyorffy","year":"2010","unstructured":"Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1809 patients. Breast Cancer Res Treat. 123, 725\u2013731 (2010).","journal-title":"Breast Cancer Res Treat."},{"key":"60730_CR153","unstructured":"Gene Ontology C. et al. The gene ontology knowledgebase in 2023. Genetics 224, iyad031 (2023)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60730-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60730-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60730-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:07:44Z","timestamp":1751357264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60730-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60730"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60730-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5608"}}